Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

NCT06040970 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Malignant Neoplasm of Uterus

Interventions

DRUG: Sacituzumab
DRUG: Cisplatin

Sponsor

Icahn School of Medicine at Mount Sinai